Format

Send to

Choose Destination
See comment in PubMed Commons below
Leukemia. 2014 May;28(5):1158-63. doi: 10.1038/leu.2014.9. Epub 2014 Jan 13.

Selinexor suppresses downstream effectors of B-cell activation, proliferation and migration in chronic lymphocytic leukemia cells.

Author information

1
Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, OH, USA.
2
Department of Veterinary Biosciences, College of Veterinary Medicine, The Ohio State University, Columbus, OH, USA.
3
Center for Biostatistics, The Ohio State University, Columbus, OH, USA.
4
Karyopharm Therapeutics Inc., Natick, MA, USA.
5
1] Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, OH, USA [2] Division of Medicinal Chemistry, College of Pharmacy, The Ohio State University, Columbus, OH, USA.
PMID:
24413321
PMCID:
PMC4013224
DOI:
10.1038/leu.2014.9
[Indexed for MEDLINE]
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Nature Publishing Group Icon for PubMed Central
    Loading ...
    Support Center